Abstract:Background Radiotherapy is one of the most important therapeutic strategies for treating cancer. For decades, studies concerning the outcomes of radiotherapy mainly focused on the biological effects of radiation on tumor cells. Recently, we have increasingly recognized that the complex cellular interactions within the tumor microenvironment (TME) are closely related to treatment outcomes. Main content As a critical component of the TME, fibroblasts participate in all stages of cancer progression. Fibroblasts are able to tolerate harsh extracellular environments, which are usually fatal to all other cells. They play pivotal roles in determining the treatment response to chemoradiotherapy. Radiotherapy activates the TME networks by inducing cycling hypoxia, modulating immune reaction, and promoting vascular regeneration, inflammation and fibrosis. While a number of studies claim that radiotherapy affects fibroblasts negatively through growth arrest and cell senescence, others argue that exposure to radiation can induce an activated phenotype in fibroblasts. These cells take an active part in constructing the tumor microenvironment by secreting cytokines and degradative enzymes. Current strategies that aim to inhibit activated fibroblasts mainly focus on four aspects: elimination, normalization, paracrine signaling blockade and extracellular matrix inhibition. This review will describe the direct cellular effects of radiotherapy on fibroblasts and the underlying genetic changes. We will also discuss the impact of fibroblasts on cancer cells during radiotherapy and the potential value of targeting fibroblasts to enhance the clinical outcome of radiotherapy. Conclusion This review provides good preliminary data to elucidate the biological roles of CAFs in radiotherapy and the clinical value of targeting CAFs as a supplementary treatment to conventional radiotherapy. Further studies to validate this strategy in more physiological models may be required before clinical trial.

Radiotherapy modulates tumor cell fate decisions: a review

Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation

Deciphering the Biological Effects of Radiotherapy in Cancer Cells

Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities

Molecular mechanisms of tumor resistance to radiotherapy

Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness

Myriad factors and pathways influencing tumor radiotherapy resistance

The scheme, and regulative mechanism of pyroptosis, ferroptosis, and necroptosis in radiation injury

Making Radiation Therapy More Effective in the Era of Precision Medicine

Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity.

Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment

Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells

Molecular Mechanisms of Chemo‐ and Radiotherapy Resistance and the Potential Implications for Cancer Treatment

Ferroptosis, radiotherapy, and combination therapeutic strategies

Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy

Effects of Radiation Therapy on Tumor Microenvironment: an Updated Review

Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy

Molecular pathways associated with oxidative stress and their potential applications in radiotherapy (Review)

Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies

Empowering Radiotherapy: Harnessing Nanomedicines to Enhance Radiation Response and Boost Antitumor Efficacy

Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope